{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T19:59:24Z","timestamp":1790452764190,"version":"4.1.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"18","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["HORIZON-MSCA-2021-SE-01"],"award-info":[{"award-number":["HORIZON-MSCA-2021-SE-01"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["Project Number 101086139-PoPMeD-SuSDeV"],"award-info":[{"award-number":["Project Number 101086139-PoPMeD-SuSDeV"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project","doi-asserted-by":"publisher","award":["2024ZD0524100"],"award-info":[{"award-number":["2024ZD0524100"]}],"id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project","doi-asserted-by":"publisher","award":["2024ZD0524101"],"award-info":[{"award-number":["2024ZD0524101"]}],"id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Science Bulletin"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.scib.2026.08.035","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T23:26:31Z","timestamp":1787181991000},"page":"4780-4789","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Estimating the economic burden of Parkinson\u2019s disease in China, 2020\u20132040: a projection and health-augmented macroeconomic modelling study"],"prefix":"10.1016","volume":"71","author":[{"given":"Yuheng","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Prettner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Kuhn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Till Winfried","family":"B\u00e4rnighausen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Bloom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simiao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maigeng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.scib.2026.08.035_b0005","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S1474-4422(06)70471-9","article-title":"Epidemiology of Parkinson's disease","volume":"5","author":"de Lau","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.scib.2026.08.035_b0010","doi-asserted-by":"crossref","first-page":"e464","DOI":"10.1016\/S2666-7568(24)00094-1","article-title":"Temporal trends in the prevalence of Parkinson's disease from 1980 to 2023: a systematic review and meta-analysis","volume":"5","author":"Zhu","year":"2024","journal-title":"Lancet Healthy Longev"},{"key":"10.1016\/j.scib.2026.08.035_b0015","article-title":"Premotor, nonmotor and motor symptoms of Parkinson's disease: a new clinical state of the art","volume":"84","author":"Silva","year":"2023","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.scib.2026.08.035_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.medp.2024.100005","article-title":"Targeting protein aggregation for the treatment of neurodegenerative diseases","volume":"1","author":"Li","year":"2024","journal-title":"Med Plus"},{"key":"10.1016\/j.scib.2026.08.035_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.medp.2024.100060","article-title":"Development of tau phosphorylation-targeting therapies for the treatment of neurodegenerative diseases","volume":"1","author":"Su","year":"2024","journal-title":"Med Plus"},{"key":"10.1016\/j.scib.2026.08.035_b0030","unstructured":"Institute for Health Metrics and Evaluation (IHME). GBD results tool. 2025. https:\/\/vizhub.healthdata.org\/gbd-results\/. Accessed 1st December 2025."},{"key":"10.1016\/j.scib.2026.08.035_b0035","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1212\/01.wnl.0000247740.47667.03","article-title":"Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030","volume":"68","author":"Dorsey","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.scib.2026.08.035_b0040","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1212\/WNL.0b013e318294b3c8","article-title":"Exposure to pesticides or solvents and risk of Parkinson disease","volume":"80","author":"Pezzoli","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.scib.2026.08.035_b0045","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41531-020-0117-1","article-title":"Current and projected future economic burden of Parkinson\u2019s disease in the U.S","volume":"6","author":"Yang","year":"2020","journal-title":"npj Parkinson's Dis"},{"key":"10.1016\/j.scib.2026.08.035_b0050","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12883-024-03988-3","article-title":"Healthcare utilization and costs for patients with Parkinson\u2019s disease in Taiwan","volume":"25","author":"Chen","year":"2025","journal-title":"BMC Neurol"},{"key":"10.1016\/j.scib.2026.08.035_b0055","article-title":"Economic burden analysis of Parkinson's Disease patients in China","volume":"2017","author":"Yang","year":"2017","journal-title":"Parkinson's Dis"},{"key":"10.1016\/j.scib.2026.08.035_b0060","doi-asserted-by":"crossref","first-page":"e401","DOI":"10.1016\/S2468-2667(25)00089-1","article-title":"Estimating global direct health-care spending on neurological and mental health between 2000 and 2019: a modelling study","volume":"10","author":"Mitchell","year":"2025","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.scib.2026.08.035_b0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40801-023-00410-1","article-title":"Economic burden of Parkinson\u2019s Disease: a multinational, real-world, cost-of-illness study","volume":"11","author":"Chaudhuri","year":"2024","journal-title":"Drugs-Real Wor Outc"},{"key":"10.1016\/j.scib.2026.08.035_b0070","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/mds.28265","article-title":"Burden of Parkinson's Disease by severity: health care costs in the U.S. medicare population","volume":"36","author":"Dahodwala","year":"2021","journal-title":"Movement Disord"},{"key":"10.1016\/j.scib.2026.08.035_b0075","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1002\/mds.29995","article-title":"Systematic review of the cost of illness of Parkinson's Disease from a societal perspective","volume":"39","author":"Wijers","year":"2024","journal-title":"Movement Disord"},{"key":"10.1016\/j.scib.2026.08.035_b0080","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1002\/mds.20999","article-title":"Economic burden of Parkinson's Disease in a developing country: a retrospective cost analysis in Shanghai, China","volume":"21","author":"Wang","year":"2006","journal-title":"Mov Disord"},{"key":"10.1016\/j.scib.2026.08.035_b0085","first-page":"26","article-title":"Estimation on direct medical cost of patients with Parkinson's Disease in China from the perspective of suppliers","volume":"38","author":"Li","year":"2021","journal-title":"Health Econ Res"},{"key":"10.1016\/j.scib.2026.08.035_b0090","doi-asserted-by":"crossref","first-page":"3238","DOI":"10.3390\/ijerph19063238","article-title":"Direct medical costs of Parkinson's disease in Southern China: a cross-sectional study based on health insurance claims data in Guangzhou City","volume":"19","author":"Zhang","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.scib.2026.08.035_b0095","doi-asserted-by":"crossref","first-page":"6","DOI":"10.17925\/ENR.2013.08.01.6","article-title":"Health economics and cost of illness in Parkinson's Disease","volume":"8","author":"Mateus","year":"2013","journal-title":"Eur Neurol Rev"},{"key":"10.1016\/j.scib.2026.08.035_b0100","first-page":"405","article-title":"The economic burden of Parkinson disease among Medicare beneficiaries","volume":"28","author":"Albarmawi","year":"2022","journal-title":"J Manag Care Spec Pharm"},{"key":"10.1016\/j.scib.2026.08.035_b0105","series-title":"Live Long and Prosper? The Economics of Ageing Populations","first-page":"44","article-title":"The flip side of \u201clive long and prosper\u201d: noncommunicable diseases in the OECD and their macroeconomic impact","author":"Bloom","year":"2019"},{"key":"10.1016\/j.scib.2026.08.035_b0110","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1377\/hlthaff.2019.00291","article-title":"Noncommunicable diseases attributable to tobacco use in China: macroeconomic burden and tobacco control policies","volume":"38","author":"Chen","year":"2019","journal-title":"Health Aff (Millwood)"},{"key":"10.1016\/j.scib.2026.08.035_b0115","article-title":"The macroeconomic burden of noncommunicable diseases associated with air pollution in China","volume":"14","author":"Chen","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.scib.2026.08.035_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.jeoa.2018.09.002","article-title":"The economic burden of chronic diseases: estimates and projections for China, Japan, and South Korea","volume":"17","author":"Bloom","year":"2020","journal-title":"J Econ Ageing"},{"key":"10.1016\/j.scib.2026.08.035_b0125","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1001\/jamaoncol.2022.7826","article-title":"Estimates and projections of the global economic cost of 29 cancers in 204 countries and territories from 2020 to 2050","volume":"9","author":"Chen","year":"2023","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.scib.2026.08.035_b0130","doi-asserted-by":"crossref","first-page":"e1534","DOI":"10.1016\/S2214-109X(24)00264-X","article-title":"The global macroeconomic burden of Alzheimer's disease and other dementias: estimates and projections for 152 countries or territories","volume":"12","author":"Chen","year":"2024","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.scib.2026.08.035_b0135","doi-asserted-by":"crossref","first-page":"e1183","DOI":"10.1016\/S2214-109X(23)00217-6","article-title":"The global economic burden of chronic obstructive pulmonary disease for 204 countries and territories in 2020-50: a health-augmented macroeconomic modelling study","volume":"11","author":"Chen","year":"2023","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.scib.2026.08.035_b0140","doi-asserted-by":"crossref","first-page":"e390","DOI":"10.1016\/S2542-5196(19)30170-6","article-title":"The global macroeconomic burden of road injuries: estimates and projections for 166 countries","volume":"3","author":"Chen","year":"2019","journal-title":"Lancet Planet Health"},{"key":"10.1016\/j.scib.2026.08.035_b0145","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/s41591-025-04027-5","article-title":"The global macroeconomic burden of diabetes mellitus","volume":"32","author":"Chen","year":"2026","journal-title":"Nat Med"},{"key":"10.1016\/j.scib.2026.08.035_b0150","article-title":"Estimating the economic burden of lower respiratory infections in China from 2020 to 2040: a health-augmented macroeconomic modelling study","volume":"69","author":"Lin","year":"2026","journal-title":"Lancet Reg Health West Pac"},{"key":"10.1016\/j.scib.2026.08.035_b0155","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/S0140-6736(25)01917-8","article-title":"Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990\u20132023: a systematic analysis for the Global Burden of Disease Study 2023","volume":"406","author":"Naghavi","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.scib.2026.08.035_b0160","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41597-020-0421-y","article-title":"Provincial and gridded population projection for China under shared socioeconomic pathways from 2010 to 2100","volume":"7","author":"Chen","year":"2020","journal-title":"Sci Data"},{"key":"10.1016\/j.scib.2026.08.035_b0165","unstructured":"National Bureau of Statistics of China. https:\/\/www.stats.gov.cn\/english\/. Accessed 10th July 2025."},{"key":"10.1016\/j.scib.2026.08.035_b0170","unstructured":"China Statistical Information Network. http:\/\/www.tjcn.org\/. Accessed 10th July 2025."},{"key":"10.1016\/j.scib.2026.08.035_b0175","unstructured":"Goldsmith RW. A perpetual inventory of national wealth. In: Studies in Income and Wealth. Princeton: Princeton University Press: NBER; 1951, p. 5\u201373. https:\/\/www.nber.org\/system\/files\/chapters\/c9716\/c9716.pdf."},{"key":"10.1016\/j.scib.2026.08.035_b0180","first-page":"17","article-title":"Reestimating the capital stock of China: 1952\u20132006","volume":"25","author":"Shan","year":"2008","journal-title":"J Quant Tech Econ"},{"key":"10.1016\/j.scib.2026.08.035_b0185","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/1756-0500-7-65","article-title":"Chinese culture permeation in the treatment of Parkinson disease: a cross-sectional study in four regions of China","volume":"7","author":"Zhang","year":"2014","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.scib.2026.08.035_b0190","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/S0140-6736(19)30427-1","article-title":"Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"394","author":"Zhou","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.scib.2026.08.035_b0195","doi-asserted-by":"crossref","first-page":"4627","DOI":"10.1002\/sim.6248","article-title":"A Bayesian generalized age-period-cohort power model for cancer projections","volume":"33","author":"Jurgens","year":"2014","journal-title":"Stat Med"},{"key":"10.1016\/j.scib.2026.08.035_b0200","doi-asserted-by":"crossref","DOI":"10.1080\/23322039.2020.1759483","article-title":"Automatic time series modeling and forecasting: a replication case study of forecasting real GDP, the unemployment rate and the impact of leading economic indicators","volume":"8","author":"Guerard","year":"2020","journal-title":"Cogent Econ Finance"},{"key":"10.1016\/j.scib.2026.08.035_b0205","first-page":"1","article-title":"Modeling GDP using autoregressive integrated moving average (ARIMA) model: a systematic review","volume":"9","author":"Muma","year":"2022","journal-title":"Open Access Libr J"},{"key":"10.1016\/j.scib.2026.08.035_b0210","series-title":"In: Proceedings of the International Conference on Applied Economics","article-title":"Modeling and forecasting of US health expenditures using ARIMA models","author":"Klazoglou","year":"2018"},{"key":"10.1016\/j.scib.2026.08.035_b0215","doi-asserted-by":"crossref","first-page":"430","DOI":"10.35808\/ersj\/2243","article-title":"The level of economic development and the savings rate of households","volume":"24","author":"Grzywi\u0144ska-R\u0105pca","year":"2021","journal-title":"Eur Res Stud J"},{"key":"10.1016\/j.scib.2026.08.035_b0220","unstructured":"Porst M, Leddin J, Rommel A, et al. Methodological report on the quantification of burden of disease indicators in the project BURDEN 2020\u2013disease frequencies, severities, durations, disability weights and sensitivity analyses. 2023. https:\/\/edoc.rki.de\/handle\/176904\/10984. Accessed 15 December 2025."},{"key":"10.1016\/j.scib.2026.08.035_b0225","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1641\/0006-3568(2001)051[0341:LNDATS]2.0.CO;2","volume":"51","author":"Limpert","year":"2001","journal-title":"Bioscience"},{"key":"10.1016\/j.scib.2026.08.035_b0230","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1038\/s41591-025-03923-0","article-title":"Global distribution of research efforts, disease burden, and impact of US public funding withdrawal","volume":"31","author":"Schmallenbach","year":"2025","journal-title":"Nat Med"},{"key":"10.1016\/j.scib.2026.08.035_b0235","doi-asserted-by":"crossref","first-page":"500","DOI":"10.7334\/psicothema2013.23","article-title":"Using the R-MAPE index as a resistant measure of forecast accuracy","volume":"25","author":"Montano Moreno","year":"2013","journal-title":"Psicothema"},{"key":"10.1016\/j.scib.2026.08.035_b0240","doi-asserted-by":"crossref","unstructured":"Muir D, Novta N, Oeking A. China's path to sustainable and balanced growth. 2024. https:\/\/www.imf.org\/-\/media\/Files\/Publications\/WP\/2024\/English\/wpiea2024238-print-pdf.ashx. Accessed 31st August 2025.","DOI":"10.5089\/9798400293467.001"},{"key":"10.1016\/j.scib.2026.08.035_b0245","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2024-080952","article-title":"Projections for prevalence of Parkinson's disease and its driving factors in 195 countries and territories to 2050: modelling study of Global Burden of Disease Study 2021","volume":"388","author":"Su","year":"2025","journal-title":"BMJ"},{"key":"10.1016\/j.scib.2026.08.035_b0250","unstructured":"Institute for Health Metrics and Evaluation (IHME). GBD Foresight Visualization. 2024. https:\/\/vizhub.healthdata.org\/gbd-foresight. Accessed 1st July 2025."},{"key":"10.1016\/j.scib.2026.08.035_b0255","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.euroneuro.2011.08.008","article-title":"Cost of disorders of the brain in Europe 2010","volume":"21","author":"Gustavsson","year":"2011","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.scib.2026.08.035_b0260","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s41256-025-00464-4","article-title":"Socioeconomic disparities in the trends of inpatient utilization for middle-aged and older adults in China: the perspective of international comparison from four cohorts","volume":"10","author":"Yuan","year":"2025","journal-title":"Glob Health Res Policy"},{"key":"10.1016\/j.scib.2026.08.035_b0265","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1186\/s12913-025-12767-w","article-title":"Assessing healthcare efficiency and determinants in China: the perspective of provincial-level social health expenditure","volume":"25","author":"Xu","year":"2025","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.scib.2026.08.035_b0270","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1177\/1757975917743533","article-title":"Healthy China 2030, a breakthrough for improving health","volume":"26","author":"Tan","year":"2019","journal-title":"Glob Health Promot"},{"key":"10.1016\/j.scib.2026.08.035_b0275","first-page":"241","article-title":"Awareness, treatment, and rehabilitation of elderly with Parkinson's Disease\u2014China, 2015\u20132017","volume":"2","author":"Zhang","year":"2020","journal-title":"China CDC Wkly"},{"key":"10.1016\/j.scib.2026.08.035_b0280","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/2047-9158-2-18","article-title":"Progress of basic research in Parkinson's Disease in China: data mini-review from the National Natural Science Foundation","volume":"2","author":"Cao","year":"2013","journal-title":"Transl Neurodegener"},{"key":"10.1016\/j.scib.2026.08.035_b0285","doi-asserted-by":"crossref","first-page":"626","DOI":"10.2471\/BLT.25.293460","article-title":"Parkinson Disease treatments on national essential medicines lists, African Region","volume":"103","author":"Fothergill-Misbah","year":"2025","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.scib.2026.08.035_b0290","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nrneurol.2018.31","article-title":"Teleneurology and mobile technologies: the future of neurological care","volume":"14","author":"Dorsey","year":"2018","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.scib.2026.08.035_b0295","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1227\/neu.0000000000002274","article-title":"Deep brain stimulation for advanced Parkinson disease in developing countries: a cost-effectiveness study from China","volume":"92","author":"Guo","year":"2023","journal-title":"Neurosurgery"},{"key":"10.1016\/j.scib.2026.08.035_bib296","doi-asserted-by":"crossref","first-page":"e797","DOI":"10.1016\/S2214-109X(23)00196-1","article-title":"Innovative methods of determining health expenditure efficiency are urgently needed","volume":"11","author":"Cao","year":"2023","journal-title":"Lancet Glob Health"}],"container-title":["Science Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095927326009254?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095927326009254?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T19:32:27Z","timestamp":1790451147000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2095927326009254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":60,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2095927326009254"],"URL":"https:\/\/doi.org\/10.1016\/j.scib.2026.08.035","relation":{},"ISSN":["2095-9273"],"issn-type":[{"value":"2095-9273","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Estimating the economic burden of Parkinson\u2019s disease in China, 2020\u20132040: a projection and health-augmented macroeconomic modelling study","name":"articletitle","label":"Article Title"},{"value":"Science Bulletin","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.scib.2026.08.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Science China Press. Published by Elsevier B.V. and Science China Press. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}